Oncopharmpod
ASCO VTE Guidelines (& more!)
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 0:26:52
- More information
Informações:
Synopsis
Updates on ASCO's updated VTE guidelines with a focus on prophylaxis for ambulatory cancer patients (1:15) and VTE treatment (12:50). Pembrolizumab's latest FDA-approval is discussed (16:00), as is pexidartinib's FDA-approval (18:00), and finally a comparison of BCOP pass rates by training status (22:34).
